Global Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Analyzers/Instruments - [Blood Gas Analyzers, Electrolyte Analyzers & Combined Analyzers], Modality - [Portable, Benchtop, Laboratory, and Consumables]

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn616213848 Published Date: June, 2025 Updated Date: July, 2025

Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market Overview

Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market (USD Million)

Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market was valued at USD 2,010.62 million in the year 2024. The size of this market is expected to increase to USD 2,930.63 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.5%.


Global Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 5.5 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.5 %
Market Size (2024)USD 2,010.62 Million
Market Size (2031)USD 2,930.63 Million
Market ConcentrationMedium
Report Pages312
2,010.62
2024
2,930.63
2031

Major Players

  • Abbott Point of Care Inc.
  • Cornley Hi-tech Co., LTD
  • Radiometer Medical ApS
  • EDAN Instruments, Inc.
  • ERBA Diagnostics Mannheim GmbH
  • F Hoffman La Roche Ltd.
  • Fortress Diagnostics
  • Instrumentation Laboratories
  • LifeHealth
  • Medica Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market

Fragmented - Highly competitive market without dominant players


The Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market is witnessing substantial growth, with advanced diagnostic solutions gaining traction in clinical environments. The integration of automated analyzers in hospitals and labs has led to over 68% of facilities adopting these systems for critical patient monitoring. These analyzers ensure rapid and accurate assessments of blood gas and electrolyte levels, streamlining treatment decisions in time-sensitive medical scenarios.

Strategic Collaborations and Partnerships
Collaborative initiatives among diagnostic equipment manufacturers and healthcare providers are shaping the future of this market. Approximately 55% of companies are engaging in partnerships to co-develop intelligent analyzer platforms that combine multiple diagnostic parameters. Such strategic moves not only enhance operational efficiency but also facilitate customized solutions for specific clinical needs, driving consistent innovation and expansion.

Opportunities and Growth Potential
The rising demand for point-of-care testing solutions is creating lucrative opportunities, with more than 63% of healthcare institutions planning to invest in portable blood gas analyzers. This shift is driven by the need for faster diagnostics, especially in remote or decentralized medical setups. The market’s growth is further reinforced by increasing awareness of preventive care strategies and improved healthcare infrastructure investments.

Future Outlook and Strategic Trends
The future outlook for the market remains strong, supported by technological upgrades, mergers, and a surge in R&D investments. Around 58% of the market's progress is expected to stem from innovations in multi-analyte testing platforms and AI-assisted interpretation tools. As healthcare systems evolve towards data-centric approaches, the emphasis on real-time, reliable diagnostic data will continue to fuel market expansion and elevate care standards.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Region
  4. Volumetric Analysis of Blood Gas and Electrolyte Analyzer MarketDynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Respiratory Diseases
        2. Point-of-Care Testing
        3. Technological Advancements
      2. Restraints
        1. Cost constraints
        2. Maintenance issues
        3. Operator training
      3. Opportunities
        1. Multi-Parameter Analysis
        2. Rapid Results
        3. Connectivity Features
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market, By Type, 2021 - 2031 (USD Million)
      1. Analyzers/Instruments
        1. Blood gas analyzers
        2. Electrolyte analyzers
        3. Combined analyzers
      2. Modality
        1. Portable
        2. Benchtop
        3. Laborator
        4. Consumables
    2. Volumetric Analysis of Blood Gas and Electrolyte Analyzer Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott Point of Care Inc.
      2. Cornley Hi-tech Co., LTD
      3. Radiometer Medical ApS
      4. EDAN Instruments, Inc.
      5. ERBA Diagnostics Mannheim GmbH
      6. F Hoffman La Roche Ltd.
      7. Fortress Diagnostics
      8. Instrumentation Laboratories
      9. LifeHealth
      10. Medica Corporation
  7. Analyst Views
  8. Future Outlook of the Market